
Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian VC investor Capricorn Partners is open to more investor approaches for its new industrial biotech fund as it aims for a final close on EUR 25m by the end of next year, partner Rob van der Meij told Unquote.
Latest News
21 Invest France eyes EUR 300m Fund VI target by year-end
Fund VI has raised half of its target so far, with the GP seeking to further prove its investment track record throughout 2023
IPEM 2023: GPs battle fundraising blues on the Côte d'Azur
Sponsors remain broadly optimistic despite fundraise bottlenecks and a growing number of LPs faced with tough choices on manager selection
Equistone to exit Acuity in sale to Permira
Sale of financial services research group follows process with early discussions between vendor and bidders
Clessidra on track for 2023 final close for debut private debt fund
GP has raised EUR 150m for the vehicle against a EUR 250m target, with one third already deployed